[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"currency-rates":3,"$fyk2oeqxpb7bd":8,"compound-J-19327-2":171,"verified-suppliers-J-19327-2":386},{"rates":4,"source":7},{"USD":5,"CNY":6},1,6.691314,"live",{"rows":9,"total":170,"current":5,"size":145},[10,33,45,60,74,85,96,113,123,135,146,158],{"slug":11,"cid":12,"imgSvg":13,"name":14,"nameZh":15,"cas":16,"formula":17,"iupac":14,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":22,"offersCount":24,"supplierCount":25,"bestOffer":26},"843627791009189888","J-1971488-8","\u002Fimages\u002Fchem_structures_svg\u002F399\u002F65845-61-6.svg","N-Methylcyclohexanamine hydrochloride","N-甲基环己胺盐酸盐","65845-61-6","C7H16ClN","acids","有机酸","Organic Acids","",[23],"In Stock",4,2,{"unitPrice":27,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},2.64,"500g","CNY","China","CN","in-stock",{"slug":34,"cid":35,"imgSvg":36,"name":37,"nameZh":38,"cas":39,"formula":40,"iupac":37,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":41,"offersCount":24,"supplierCount":5,"bestOffer":42},"785882541994283008","J-1323843-4","\u002Fimages\u002Fchem_structures_svg\u002F104\u002F67627-18-3.svg","Potassium indigotrisulfonate","靛蓝三磺酸钾","67627-18-3","C16H7K3N2O11S3",[23],{"unitPrice":43,"pack":44,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},180,"5g",{"slug":46,"cid":47,"imgSvg":48,"name":49,"nameZh":50,"cas":51,"formula":52,"iupac":49,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":56,"offersCount":57,"supplierCount":25,"bestOffer":58},"785889752443260928","J-28559-9","\u002Fimages\u002Fchem_structures_svg\u002F292\u002F15060-55-6.svg","Ammonium tetrathiomolybdate","四硫钼酸铵","15060-55-6","H8MoN2S4","inorganic","无机化合物","Inorganic Chemicals",[23],7,{"unitPrice":59,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},24,{"slug":61,"cid":62,"imgSvg":63,"name":64,"nameZh":65,"cas":66,"formula":67,"iupac":64,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":68,"offersCount":69,"supplierCount":25,"bestOffer":70},"855452191530422272","J-1994428-7","\u002Fimages\u002Fchem_structures_svg\u002F500\u002F16350-96-2.svg","N-benzylcyclohexanamine.hydrochloride","N-苄基环己胺盐酸盐","16350-96-2","C13H20ClN",[23],5,{"unitPrice":71,"pack":72,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},6,"1000g","中国",{"slug":75,"cid":76,"imgSvg":77,"name":78,"nameZh":79,"cas":80,"formula":81,"iupac":78,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":82,"offersCount":25,"supplierCount":25,"bestOffer":83},"785871840001134592","J-982001-0","\u002Fimages\u002Fchem_structures_svg\u002F001\u002F10517-44-9.svg","1,3-Diaminopropane dihydrochloride","1,3-二氨基丙烷二盐酸盐","10517-44-9","C3H12Cl2N2",[23],{"unitPrice":84,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},3.78,{"slug":86,"cid":87,"imgSvg":88,"name":89,"nameZh":90,"cas":91,"formula":92,"iupac":89,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":93,"offersCount":57,"supplierCount":94,"bestOffer":95},"785880365658017792","J-14975-6","\u002Fimages\u002Fchem_structures_svg\u002F262\u002F12003-67-7.svg","Lithium aluminate","氧化铝锂","12003-67-7","AlHLiO2",[23],3,{"unitPrice":94,"pack":28,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},{"slug":97,"cid":98,"imgSvg":99,"name":100,"nameZh":101,"cas":102,"formula":103,"iupac":100,"category":104,"categoryName":105,"categoryEnName":106,"industry":21,"tags":107,"offersCount":108,"supplierCount":108,"bestOffer":109},"785871830249377792","J-6931-9","\u002Fimages\u002Fchem_structures_svg\u002F456\u002F58068-80-7.svg","1-Octanoylbenzotriazole","N-辛酰苯并三唑","58068-80-7","C14H19N3O","aromatics","芳香烃","Aromatic Hydrocarbons",[],0,{"unitPrice":110,"pack":21,"currency":111,"origin":21,"originFlag":21,"moq":21,"stock":112},9007199254740991,"USD","made-to-order",{"slug":114,"cid":115,"imgSvg":116,"name":117,"nameZh":118,"cas":119,"formula":120,"iupac":117,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":121,"offersCount":69,"supplierCount":25,"bestOffer":122},"785871842446413824","J-1960944-3","\u002Fimages\u002Fchem_structures_svg\u002F495\u002F10534-86-8.svg","Hexaamminecobalt(III) nitrate","六氨合钴(III)硝酸盐","10534-86-8","CoH18N9O9",[23],{"unitPrice":71,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},{"slug":124,"cid":125,"imgSvg":126,"name":127,"nameZh":128,"cas":129,"formula":130,"iupac":127,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":131,"offersCount":24,"supplierCount":25,"bestOffer":132},"785871842576437248","J-814544-6","\u002Fimages\u002Fchem_structures_svg\u002F221\u002F12037-42-2.svg","vanadium oxide","氧化钒","12037-42-2","O13V6",[23],{"unitPrice":133,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},112.8,"100g",{"slug":136,"cid":137,"imgSvg":138,"name":139,"nameZh":140,"cas":141,"formula":142,"iupac":139,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":143,"offersCount":57,"supplierCount":5,"bestOffer":144},"785871842647740416","J-1333345-2","\u002Fimages\u002Fchem_structures_svg\u002F479\u002F26490-63-1.svg","COBALT TETRAFLUOROBORATE HEXAHYDRATE","四氟化硼钴水合物","26490-63-1","B2CoF8H12O6",[23],{"unitPrice":145,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},12,{"slug":147,"cid":148,"imgSvg":149,"name":150,"nameZh":151,"cas":152,"formula":153,"iupac":150,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":154,"offersCount":155,"supplierCount":94,"bestOffer":156},"785871842698072064","J-814953-0","\u002Fimages\u002Fchem_structures_svg\u002F432\u002F72259-10-0.svg","Copper(II) tetrafluoroborate hexahydrate","六水合四氟硼酸铜(II)","72259-10-0","B2CuF8H12O6",[23],10,{"unitPrice":157,"pack":28,"currency":29,"origin":21,"originFlag":21,"moq":21,"stock":32},2.6,{"slug":159,"cid":160,"imgSvg":161,"name":162,"nameZh":163,"cas":164,"formula":165,"iupac":162,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":166,"offersCount":25,"supplierCount":5,"bestOffer":168},"785871863254355968","J-1990080-7","\u002Fimages\u002Fchem_structures_svg\u002F149\u002F123333-60-8.svg","Cerium(IV) sulfate hydrate","铈(IV)硫酸盐水合物","123333-60-8","CeH2O9S2",[167],"Made to Order",{"unitPrice":169,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},5.6,3204,{"slug":172,"cid":173,"imgSvg":174,"name":175,"nameZh":175,"cas":176,"formula":177,"iupac":175,"mdl":21,"mw":178,"category":179,"categoryName":180,"categoryEnName":181,"industry":21,"tags":182,"synonyms":183,"properties":187,"ghs":242,"offers":243,"activity":244,"upstream":269,"downstream":306,"customs":313,"safetyRows":317,"synthesis":343,"msds":344,"updatedAt":345,"isProhibited":346,"related":347,"__ts":384,"__lang":385,"__slug":173},"785881425940320256","J-19327-2","\u002Fimages\u002Fchem_structures_svg\u002F016\u002F123948-87-8.svg","拓扑替康","123948-87-8","C23H23N3O5","421.446","organic","有机化合物","Organic Compounds",[],[184,185,186],"托泊替康","托扑替康","(S)-10-[(二甲氨基)甲基]-4-乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]中氮茚并[1,2-B]喹啉-3,14(4H,12H)-二酮",[188,192,196,200,204,208,211,214,217,220,224,228,232,235,239],{"label":189,"labelZh":189,"value":190,"prop":191},"Melting Point","−114 °C(lit.)","meltingPoint",{"label":193,"labelZh":193,"value":194,"prop":195},"Boiling Point","782.9±60.0 °C at 760 mmHg","boilingPoint",{"label":197,"labelZh":197,"value":198,"prop":199},"Density","1.5±0.1 g\u002Fcm3","density",{"label":201,"labelZh":201,"value":202,"prop":203},"Flash Point","427.3±32.9 °C","flashPoint",{"label":205,"labelZh":206,"value":207},"Exact Mass","精确质量","421.163757",{"label":209,"labelZh":209,"value":210},"PSA","104.89000",{"label":212,"labelZh":212,"value":213},"LogP","1.08",{"label":215,"labelZh":215,"value":216},"外观性状","淡黄色针状晶体或结晶粉末",{"label":218,"labelZh":218,"value":219},"蒸汽密度","1.3 (vs air)",{"label":221,"labelZh":222,"value":223},"Vapor Pressure","蒸汽压","0.0±2.8 mmHg at 25°C",{"label":225,"labelZh":226,"value":227},"Refractive Index","折射率","1.734",{"label":229,"labelZh":230,"value":231},"Storage Conditions","储存条件","2-8°C",{"label":233,"labelZh":233,"value":234},"水溶解性","H2O: soluble",{"label":236,"labelZh":237,"value":238},"Molecular Structure","分子结构","1、 摩尔折射率：112.73\n2、 摩尔体积（cm\n3\n\u002Fmol）：281.3\n3、 等张比容（90.2K）：848.8\n4、 表面张力（dyne\u002Fcm）：82.8\n5、 极化率（10-24cm3）：44.69",{"label":240,"labelZh":240,"value":241},"更多","1.性状：浅黄色针状结晶或结晶粉末。\n2.熔点（ºC）：213~218\n3.溶解性：在水中溶解度大于1mg\u002Fml。",null,[],[245,248,251,254,257,260,263,266],{"key":246,"value":247},"描述","Topotecan (SKF 104864A; NSC 609669) 是拓扑异构酶I抑制剂。",{"key":249,"value":250},"相关类别","信号通路\n>>\n自噬\n>>\n自噬\n研究领域\n>>\n癌症",{"key":252,"value":253},"靶点","Topoisomerase I",{"key":255,"value":256},"体外研究","托泊替康(SKF104864)不仅以剂量和时间依赖的方式明显抑制人胶质瘤细胞和胶质瘤干细胞(GSCs)的增殖。根据24小时的IC50值,选择3μM托泊替康(SKF104864)作为最佳给药浓度。此外,拓扑替康(SKF104864)在G0\u002FG1期和S期诱导细胞周期停滞并促进细胞凋亡。结果显示拓扑替康(SKF104864)以剂量依赖性方式抑制细胞活力。与对照组相比,2,20和40μM的拓扑替康明显抑制细胞活力。拓扑替康(SKF104864)在24小时的IC 50值为2.73±0.25μM的U251细胞,2.95±0.23μM的U87细胞,5.46±0.41μM的GSCs-U251和5.95±0.24μM的GSCs-U87。因此,在随后的实验中选择3μM拓扑替康作为最佳给药浓度[1]。",{"key":258,"value":259},"体内研究","NUB-7转移模型,处理14天后处死属于所有4组的动物。与对照相比,TP + PZ处理的动物与PZ相比,低剂量节拍(LDM)托泊替康(TP)和TP +帕唑帕尼(PZ)肝重显着降低。除了TP + PZ之外,在属于所有组的小鼠的肝脏中可见微观肿瘤,证实了TP + PZ控制肝转移的能力。在先前的剂量反应研究中,与每周最大耐受剂量方案(7.5和15 mg\u002Fkg)相比,口服节拍托泊替康(0.5,1.0和1.5 mg\u002Fkg)的日剂量导致微血管密度降低更多。卵巢癌模型,但每天用1.5 mg\u002Fkg治疗的小鼠,口服托泊替康显示食物摄入量减少,抗肿瘤作用较小[2]。",{"key":261,"value":262},"细胞实验","将U251，U87，GSCs-U251和GSCs-U87细胞分别以每孔2×104个细胞的密度接种在96孔板中，并孵育24小时。用紫草素和拓扑替康（0.02,0.2,2,20,40μM）给予细胞。处理后，将10μL细胞计数试剂盒-8（CCK-8）加入各孔中，在37℃下再孵育1小时。用酶标仪在450nm处读取光密度（OD）[1]。",{"key":264,"value":265},"动物实验","小鼠[2]对于皮下异种移植研究，我们使用SK-N-BE，SH-SY5Y，KHOS和RH30。将1×10 6个细胞皮下植入每只非肥胖糖尿病\u002F严重联合免疫缺陷（NOD \u002F SCID）小鼠的腹股沟脂肪垫中。当肿瘤直径达到0.5cm时，将动物随机分成4组，每天通过口服强饲法治疗。动物分为：对照组，LDM拓扑替康组或LDM TP（1 mg \u002F kg托泊替康），帕唑帕尼组或PZ（150 mg \u002F kg帕唑帕尼）和联合用药组或TP + PZ（1 mg \u002F kg托泊替康+ 150 mg \u002F kg Pazopanib）。为了在KHOS骨肉瘤模型中比较脉冲托泊替康与LDM TP，用每周口服剂量的脉冲拓扑替康（SKF104864）或脉冲TP（15mg \u002F kg拓扑替康（SKF104864））代替PZ。终点的标准是直径超过2.0cm的肿瘤大小或显示出发病迹象的动物。每天测量肿瘤大小直至终点或处死。用卡尺测量长（D）和短直径（d）。肿瘤体积（cm 3）计算为V = 0.5×D×d2。当达到终点或治疗结束时，通过颈椎脱位处死动物。",{"key":267,"value":268},"参考文献","[1].\nZhang FL, et al. PLoS One. 2013 Nov 26;8(11):e81815.Topoisomerase I inhibitors, Shikonin and Topotecan, inhibit growth and induce apoptosis of glioma cells andglioma stem cells.\n[2].\nKumar S, et al. Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor. Clin Cancer Res. 2011 Sep 1;17(17):5656-67.",[270,276,282,288,294,300],{"slug":271,"cid":272,"name":273,"nameZh":273,"cas":274,"imgSvg":275},"785894615348678700","J-38286-7","(S)-10-羟基喜树碱","19685-09-7","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F365\u002F19685-09-7.svg",{"slug":277,"cid":278,"name":279,"nameZh":279,"cas":280,"imgSvg":281},"785892978949361700","J-34386-4","N,N-二甲基亚甲蓝","30354-18-8","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F358\u002F30354-18-8.svg",{"slug":283,"cid":284,"name":285,"nameZh":285,"cas":286,"imgSvg":287},"785882318953779200","J-3043-0","二氯甲烷","75-09-2","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F041\u002F75-09-2.svg",{"slug":289,"cid":290,"name":291,"nameZh":291,"cas":292,"imgSvg":293},"785897803602726900","J-47969-5","二甲胺","124-40-3","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F292\u002F124-40-3.svg",{"slug":295,"cid":296,"name":297,"nameZh":297,"cas":298,"imgSvg":299},"785893945669324800","J-1327339-8","甲醛","50-00-0","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F069\u002F50-00-0.svg",{"slug":301,"cid":302,"name":303,"nameZh":303,"cas":304,"imgSvg":305},"785875944408617000","J-11410-7","喜树碱","7689-03-4","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F483\u002F7689-03-4.svg",[307],{"slug":308,"cid":309,"name":310,"nameZh":310,"cas":311,"imgSvg":312},"785893656845357000","J-1324376-6","盐酸拓扑替康","119413-54-6","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F492\u002F119413-54-6.svg",[314],{"key":315,"value":316},"海关编码","2942000000",[318,321,324,327,330,333,336,339,342],{"key":319,"value":320},"危害码 (欧洲)","T,C,F,Xi",{"key":322,"value":323},"风险声明 (欧洲)","R36\u002F37\u002F38",{"key":325,"value":326},"安全声明 (欧洲)","S26-S45-S36\u002F37\u002F39",{"key":328,"value":329},"危险品运输编码","UN 3286 3\u002FPG 2",{"key":331,"value":332},"WGK德国","2",{"key":334,"value":335},"RTECS号","MW4025000",{"key":337,"value":338},"包装等级","II",{"key":340,"value":341},"危险类别","8",{"key":315,"value":316},"\u003Cp>羟基喜树碱用37%甲醛和40%二甲胺，在乙酸中进行胺甲基化，得到产物。\u003C\u002Fp>\u003Cp>\u003C\u002Fp>","\u003Ctd>\n\n\n\u003Cstrong>模块1. 化学品\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>1.1 产品标识符\u003C\u002Fb>\n\u003Cbr \u002F> : Topotecan Hydrochloride Hydrate\n\u003Cbr \u002F> 产品名称\n\u003Cbr \u002F>\n\u003Cb>1.2 鉴别的其他方法\u003C\u002Fb>\n\u003Cbr \u002F> NSC-609669\n\u003Cbr \u002F> SKF-104864A\n\u003Cbr \u002F> 9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin hydrochloride\n\u003Cbr \u002F> hycamptamine hydrochloride\n\u003Cbr \u002F> Nogitecan hydrochloride\n\u003Cbr \u002F>\n\u003Cb>1.3 有关的确定了的物质或混合物的用途和建议不适合的用途\u003C\u002Fb>\n\u003Cbr \u002F> 仅用于研发。不作为药品、家庭或其它用途。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块2. 危险性概述\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>2.1 GHS-分类\u003C\u002Fb>\n\u003Cbr \u002F> 生殖细胞致突变性 (类别 2)\n\u003Cbr \u002F>\n\u003Cb>2.2 GHS 标记要素，包括预防性的陈述\u003C\u002Fb>\n\u003Cbr \u002F> 象形图\n\u003Cbr \u002F> 警示词警告\n\u003Cbr \u002F> 危险申明\n\u003Cbr \u002F> H341怀疑会导致遗传性缺陷。\n\u003Cbr \u002F> 警告申明\n\u003Cbr \u002F> 预防措施\n\u003Cbr \u002F> P201在使用前获取特别指示。\n\u003Cbr \u002F> P202在读懂所有安全防范措施之前切勿操作。\n\u003Cbr \u002F> P280戴防护手套\u002F穿防护服\u002F戴护目镜\u002F戴面罩.\n\u003Cbr \u002F> 事故响应\n\u003Cbr \u002F> P308 + P313如接触到或有疑虑：求医\u002F 就诊。\n\u003Cbr \u002F> 安全储存\n\u003Cbr \u002F> P405存放处须加锁。\n\u003Cbr \u002F> 废弃处置\n\u003Cbr \u002F> P501将内容物\u002F 容器处理到得到批准的废物处理厂。\n\u003Cbr \u002F> 只限于专业使用者。\n\u003Cbr \u002F>\n\u003Cb>2.3 其它危害物 - 无\u003C\u002Fb>\n\u003Cbr \u002F>\n\n\u003Cstrong>模块3. 成分\u002F组成信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>3.1 物 质\u003C\u002Fb>\n\u003Cbr \u002F> : NSC-609669\n\u003Cbr \u002F> 别名\n\u003Cbr \u002F> SKF-104864A\n\u003Cbr \u002F> 9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin hydrochloride\n\u003Cbr \u002F> hycamptamine hydrochloride\n\u003Cbr \u002F> Nogitecan hydrochloride\n\u003Cbr \u002F> : C23H23N3O5·xHCl·yH2O\n\u003Cbr \u002F> 分子式\n\u003Cbr \u002F> : 421.45 g\u002Fmol\n\u003Cbr \u002F> 分子量\n\u003Cbr \u002F> 组分浓度或浓度范围\n\u003Cbr \u002F> TOPOTECAN HYDROCHLORIDE HYDRATE\n\u003Cbr \u002F> <=100%\n\u003Cbr \u002F> 化学文摘登记号(CAS 123948-87-8\n\u003Cbr \u002F> No.)\n\u003Cbr \u002F>\n\n\u003Cstrong>模块4. 急救措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>4.1 必要的急救措施描述\u003C\u002Fb>\n\u003Cbr \u002F> 一般的建议\n\u003Cbr \u002F> 请教医生。 向到现场的医生出示此安全技术说明书。\n\u003Cbr \u002F> 吸入\n\u003Cbr \u002F> 如果吸入,请将患者移到新鲜空气处。 如呼吸停止,进行人工呼吸。 请教医生。\n\u003Cbr \u002F> 皮肤接触\n\u003Cbr \u002F> 用肥皂和大量的水冲洗。 请教医生。\n\u003Cbr \u002F> 眼睛接触\n\u003Cbr \u002F> 用水冲洗眼睛作为预防措施。\n\u003Cbr \u002F> 食入\n\u003Cbr \u002F> 切勿给失去知觉者通过口喂任何东西。 用水漱口。 请教医生。\n\u003Cbr \u002F>\n\u003Cb>4.2 主要症状和影响，急性和迟发效应\u003C\u002Fb>\n\u003Cbr \u002F> 摄入可能会引起肠胃刺激,恶心,呕吐和腹泻。, 疲劳, 骨髓毒性,\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。\n\u003Cbr \u002F>\n\u003Cb>4.3 及时的医疗处理和所需的特殊处理的说明和指示\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块5. 消防措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>5.1 灭火介质\u003C\u002Fb>\n\u003Cbr \u002F> 灭火方法及灭火剂\n\u003Cbr \u002F> 用水雾,抗乙醇泡沫,干粉或二氧化碳灭火。\n\u003Cbr \u002F>\n\u003Cb>5.2 源于此物质或混合物的特别的危害\u003C\u002Fb>\n\u003Cbr \u002F> 碳氧化物, 氮氧化物, 氯化氢气体\n\u003Cbr \u002F>\n\u003Cb>5.3 给消防员的建议\u003C\u002Fb>\n\u003Cbr \u002F> 如必要的话,戴自给式呼吸器去救火。\n\u003Cbr \u002F>\n\u003Cb>5.4 进一步信息\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块6. 泄露应急处理\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>6.1 作业人员防护措施、防护装备和应急处置程序\u003C\u002Fb>\n\u003Cbr \u002F> 使用个人防护用品。 避免粉尘生成。 避免吸入蒸气、烟雾或气体。 保证充分的通风。\n\u003Cbr \u002F> 人员疏散到安全区域。 避免吸入粉尘。\n\u003Cbr \u002F>\n\u003Cb>6.2 环境保护措施\u003C\u002Fb>\n\u003Cbr \u002F> 如能确保安全，可采取措施防止进一步的泄漏或溢出。 不要让产品进入下水道。\n\u003Cbr \u002F>\n\u003Cb>6.3 泄漏化学品的收容、清除方法及所使用的处置材料\u003C\u002Fb>\n\u003Cbr \u002F> 收集和处置时不要产生粉尘。 扫掉和铲掉。 放入合适的封闭的容器中待处理。\n\u003Cbr \u002F>\n\u003Cb>6.4 参考其他部分\u003C\u002Fb>\n\u003Cbr \u002F> 丢弃处理请参阅第13节。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块7. 操作处置与储存\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>7.1 安全操作的注意事项\u003C\u002Fb>\n\u003Cbr \u002F> 避免接触皮肤和眼睛。 避免形成粉尘和气溶胶。\n\u003Cbr \u002F> 在有粉尘生成的地方,提供合适的排风设备。\n\u003Cbr \u002F>\n\u003Cb>7.2 安全储存的条件,包括任何不兼容性\u003C\u002Fb>\n\u003Cbr \u002F> 贮存在阴凉处。 使容器保持密闭，储存在干燥通风处。\n\u003Cbr \u002F> 建议的贮存温度： -20 °C\n\u003Cbr \u002F>\n\u003Cb>7.3 特定用途\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块8. 接触控制和个体防护\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>8.1 容许浓度\u003C\u002Fb>\n\u003Cbr \u002F> 最高容许浓度\n\u003Cbr \u002F> 没有已知的国家规定的暴露极限。\n\u003Cbr \u002F>\n\u003Cb>8.2 暴露控制\u003C\u002Fb>\n\u003Cbr \u002F> 适当的技术控制\n\u003Cbr \u002F> 根据良好的工业卫生和安全规范进行操作。 休息前和工作结束时洗手。\n\u003Cbr \u002F> 个体防护设备\n\u003Cbr \u002F> 眼\u002F面保护\n\u003Cbr \u002F> 带有防护边罩的安全眼镜符合 EN166要求请使用经官方标准如NIOSH (美国) 或 EN 166(欧盟)\n\u003Cbr \u002F> 检测与批准的设备防护眼部。\n\u003Cbr \u002F> 皮肤保护\n\u003Cbr \u002F> 戴手套取 手套在使用前必须受检查。\n\u003Cbr \u002F> 请使用合适的方法脱除手套(不要接触手套外部表面),避免任何皮肤部位接触此产品.\n\u003Cbr \u002F> 使用后请将被污染过的手套根据相关法律法规和有效的实验室规章程序谨慎处理. 请清洗并吹干双手\n\u003Cbr \u002F> 所选择的保护手套必须符合EU的89\u002F686\u002FEEC规定和从它衍生出来的EN 376标准。\n\u003Cbr \u002F> 身体保护\n\u003Cbr \u002F> 防渗透的衣服, 防护设备的类型必须根据特定工作场所中的危险物的浓度和数量来选择。\n\u003Cbr \u002F> 呼吸系统防护\n\u003Cbr \u002F> 如危险性评测显示需要使用空气净化的防毒面具，请使用全面罩式多功能微粒防毒面具N100型（US\n\u003Cbr \u002F> ）或P3型（EN\n\u003Cbr \u002F> 143）防毒面具筒作为工程控制的候补。如果防毒面具是保护的唯一方式，则使用全面罩式送风防毒\n\u003Cbr \u002F> 面具。 呼吸器使用经过测试并通过政府标准如NIOSH（US）或CEN（EU）的呼吸器和零件。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块9. 理化特性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>9.1 基本的理化特性的信息\u003C\u002Fb>\n\u003Cbr \u002F> a) 外观与性状\n\u003Cbr \u002F> 形状: 固体\n\u003Cbr \u002F> b) 气味\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> c) 气味阈值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> d) pH值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> e) 熔点\u002F凝固点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> f) 沸点、初沸点和沸程\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> g) 闪点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> h) 蒸发速率\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> i) 易燃性(固体,气体)\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> j) 高的\u002F低的燃烧性或爆炸性限度 无数据资料\n\u003Cbr \u002F> k) 蒸气压\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> l) 蒸汽密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> m) 密度\u002F相对密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> n) 水溶性\n\u003Cbr \u002F> 可溶的\n\u003Cbr \u002F> o) n-辛醇\u002F水分配系数\n\u003Cbr \u002F> 辛醇--水的分配系数的对数值: -0.039\n\u003Cbr \u002F> p) 自燃温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> q) 分解温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> r) 粘度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块10. 稳定性和反应活性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>10.1 反应性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.2 稳定性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.3 危险反应\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.4 应避免的条件\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.5 不相容的物质\u003C\u002Fb>\n\u003Cbr \u002F> 强氧化剂\n\u003Cbr \u002F>\n\u003Cb>10.6 危险的分解产物\u003C\u002Fb>\n\u003Cbr \u002F> 其它分解产物 - 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块11. 毒理学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>11.1 毒理学影响的信息\u003C\u002Fb>\n\u003Cbr \u002F> 急性毒性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> TDLo 静脉内的 - 人 - 0.05 mg\u002Fkg\n\u003Cbr \u002F> 备注: 血：其他改变。\n\u003Cbr \u002F> 皮肤刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 眼睛刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 呼吸道或皮肤过敏\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 生殖细胞致突变性\n\u003Cbr \u002F> 离体试验表明有致突变效应\n\u003Cbr \u002F> 细胞突变性-体外试验 - 人 - 其他细胞类型\n\u003Cbr \u002F> 细胞突变性-体外试验 - 仓鼠 - 子宫\n\u003Cbr \u002F> 细胞突变性-体外试验 - 仓鼠 - 成纤维细胞\n\u003Cbr \u002F> 细胞突变性-体内试验 - 小鼠 - 腹膜内的\n\u003Cbr \u002F> 细胞突变性-体内试验 - 小鼠 - 腹膜内的\n\u003Cbr \u002F> 致癌性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> IARC:\n\u003Cbr \u002F> 此产品中没有大于或等于 0。1%含量的组分被 IARC鉴别为可能的或肯定的人类致癌物。\n\u003Cbr \u002F> 生殖毒性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 特异性靶器官系统毒性（一次接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 特异性靶器官系统毒性（反复接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 吸入危险\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 潜在的健康影响\n\u003Cbr \u002F> 吸入吸入可能有害。 可能引起呼吸道刺激。\n\u003Cbr \u002F> 摄入如服入是有害的。\n\u003Cbr \u002F> 皮肤通过皮肤吸收可能有害。 可能引起皮肤刺激。\n\u003Cbr \u002F> 眼睛可能引起眼睛刺激。\n\u003Cbr \u002F> 接触后的征兆和症状\n\u003Cbr \u002F> 摄入可能会引起肠胃刺激,恶心,呕吐和腹泻。, 疲劳, 骨髓毒性,\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。\n\u003Cbr \u002F> 附加说明\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的\n\u003Cbr \u002F> 血：血小板减少 症。\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的 - 雌性\n\u003Cbr \u002F> 血：细胞数量改变（非特异的）。\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的\n\u003Cbr \u002F> 血：细胞数量改变（非特异的）。\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的\n\u003Cbr \u002F> 血：血小板减少 症。\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的\n\u003Cbr \u002F> 肿瘤发生作用：卵巢肿瘤。\n\u003Cbr \u002F> 反复染毒毒性 - 哺乳动物的\n\u003Cbr \u002F> 肿瘤发生作用：卵巢肿瘤。\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠 - 经口\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠 - 经口\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠 - 经口\n\u003Cbr \u002F> 营养与总代谢：体重降低或体重增长减小。\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠 - 经口\n\u003Cbr \u002F> 反复染毒毒性 - 小鼠 - 经口\n\u003Cbr \u002F> 化学物质毒性作用登记: 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块12. 生态学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>12.1 生态毒性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.2 持久性和降解性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.3 潜在的生物累积性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.4 土壤中的迁移性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.5 PBT 和 vPvB的结果评价\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.6 其它不良影响\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块13. 废弃处置\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>13.1 废物处理方法\u003C\u002Fb>\n\u003Cbr \u002F> 产品\n\u003Cbr \u002F> 将剩余的和不可回收的溶液交给有许可证的公司处理。\n\u003Cbr \u002F> 与易燃溶剂相溶或者相混合，在备有燃烧后处理和洗刷作用的化学焚化炉中燃烧\n\u003Cbr \u002F> 受污染的容器和包装\n\u003Cbr \u002F> 按未用产品处置。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块14. 运输信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>14.1 联合国危险货物编号\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.2 联合国运输名称\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 非危险货物\n\u003Cbr \u002F> 国际海运危规: 非危险货物\n\u003Cbr \u002F> 国际空运危规: 非危险货物\n\u003Cbr \u002F>\n\u003Cb>14.3 运输危险类别\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.4 包裹组\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.5 环境危险\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 否国际海运危规国际空运危规: 否\n\u003Cbr \u002F> 海洋污染物（是\u002F否）: 否\n\u003Cbr \u002F>\n\u003Cb>14.6 对使用者的特别提醒\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cbr \u002F>\n\n\u003Cstrong> 模块 15 - 法规信息 \u003C\u002Fstrong>\n\u003Cbr \u002F>N\u002FA\n\u003Cbr \u002F>\n\u003Cbr \u002F>\n\n\u003Cstrong> 模块16 - 其他信息 \u003C\u002Fstrong>\n\u003Cbr \u002F>N\u002FA\n\u003Cbr \u002F>\n\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\n\u003C\u002Ftd>","2026-08-21T07:51:12.859463Z",false,[348,354,360,366,372,378],{"slug":349,"cid":350,"name":351,"nameZh":352,"cas":353},"785889757879078912","J-1372965-3","Calcium Saccharin Hydrate","糖精钙水合物","6381-91-5",{"slug":355,"cid":356,"name":357,"nameZh":358,"cas":359},"785881577656684544","J-1111912-6","Mordant Black 17","铬蓝黑R","2538-85-4",{"slug":361,"cid":362,"name":363,"nameZh":364,"cas":365},"785881331014832128","J-18850-2","Diosgenin","薯蓣皂苷元","512-04-9",{"slug":367,"cid":368,"name":369,"nameZh":370,"cas":371},"785897866148188160","J-1065587-2","Noscapine","那可丁","128-62-1",{"slug":373,"cid":374,"name":375,"nameZh":376,"cas":377},"785882335940710400","J-3147-5","Pigment Red 57:1","颜料红57:1","5281-04-9",{"slug":379,"cid":380,"name":381,"nameZh":382,"cas":383},"785898367673700352","J-1988074-7","Pantoprazole Sodium Sesquihydrate","泮托拉唑钠倍半水合物","164579-32-2",1792618574391,"zh-CN",[]]